MARKET OUTLOOK
Triton Market Research predicts that the Indonesia market for continuous glucose monitoring system comprising (CGMS) and self-monitoring of blood glucose (SMBG) would witness a CAGR of 21.21% and 11.25% respectively, over the forecasting years of 2019-2025.
The rise in the prevalence of diabetes, along with increased R&D, have proven to be major driving factors for the growth of the glucose monitoring system market in Indonesia. The increasing cases of diabetes in the country can be attributed to the unhealthy eating habits, sedentary lifestyles and reduced physical activity amongst people. However, the market does face certain hindrances to growth, such as issues concerning approval and regulation by government authorities. Professionals in the field, as well as patients, are not aware of the latest technological advancements, which further curtails the market growth.
COMPETITIVE OUTLOOK
The companies that have been mentioned in the Indonesia glucose monitoring system market report are ARKRAY, Inc., i-SENS, Inc., B Braun Melsungen AG, Abbott, Becton Dickinson and Company, Roche Diagnostics and Johnson & Johnson.